MARTIRE, Serena
MARTIRE, Serena
NEUROSCIENZE "RITA LEVI MONTALCINI"
In multiple sclerosis patients a single serum neurofilament light chain (sNFL) dosage is strongly associated with 12 months outcome: data from a real-life clinical setting
2024-01-01 Malucchi S.; Bava C.I.; Valentino P.; Martire S.; Lo Re M.; Bertolotto A.; Di Sapio A.
NURR1-deficient mice have age- and sex-specific behavioral phenotypes
2022-01-01 Montarolo F.; Martire S.; Chiara F.; Allegra S.; De Francia S.; Hoxha E.; Tempia F.; Capobianco M.A.; Bertolotto A.
Overexpression of the ubiquitin-editing enzyme A20 in the brain lesions of Multiple Sclerosis patients: moving from systemic to central nervous system inflammation
2021-01-01 Perga S.; Montarolo F.; Martire S.; Bonaldo B.; Bono G.; Bertolo J.; Magliozzi R.; Bertolotto A.
Prevalence of elevated sNFL in a real-world setting: Results on 908 patients with different multiple sclerosis types and treatment conditions
2024-01-01 Bava, Cecilia Irene; Valentino, Paola; Malucchi, Simona; Bottero, Rugiada; Martire, Serena; Sapio, Alessia Di; Bertolotto, Antonio
Serum Neurofilaments are a reliable biomarker to early detect PML in Multiple Sclerosis patients
2023-01-01 Valentino P.; Malucchi S.; Bava C.I.; Martire S.; Capobianco M.; Malentacchi M.; Sperli F.; Oggero A.; Di Sapio A.; Bertolotto A.
Tailoring Rituximab According to CD27-Positive B-Cell versus CD19-Positive B-Cell Monitoring in Neuromyelitis Optica Spectrum Disorder and MOG-Associated Disease: Results from a Single-Center Study
2023-01-01 Bruschi N.; Malentacchi M.; Malucchi S.; Sperli F.; Martire S.; Sala A.; Valentino P.; Bertolotto A.; Pautasso M.; Capobianco M.A.
The Selective Agonist for Sphingosine-1-Phosphate Receptors Siponimod Increases the Expression Level of NR4A Genes in Microglia Cell Line
2022-01-01 Montarolo F.; Martire S.; Marnetto F.; Valentino P.; Valverde S.; Capobianco M.A.; Bertolotto A.